1. Marti F, Vollenweider P, Marques-Vidal PM, et al. Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health, 2011. 11,733. https://doi.org/10.1186/1471-2458-11-733
2. Ponte B, Pruijm M, Marques-Vidal P, et al. Determinants and burden of chronic kidney disease in the population-based CoLaus study: a cross-sectional analysis. Nephrol Dial Transplant, 2013. 28:2329-2339. Doi: 10.1093/ndt/gft206. Epub 2013 Jul 3.
3. Ciancolo G, De Pascalis A, Di Lullo L, et al. Folic Acid and Homocysteine in Chronic Kidney Disease and cardiovascular Disease Progression: Which comes first. Cardiorenal Med, 2017. 7:255-266 https://doi.org/10.1159/000471813
4. Yee J. Albuminuria and Prognosis in CKD: Truth Be Told. Advances in Chronic Kidney Disease, 2011. Vol 18, No 4: pp 219-221. doi:10.1053/j.ackd.2011.06.007
5. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ, 2002. 325(7374):1202. Doi: 10.1136/bmj.325.7374.1202
6. Homocysteine studies collaborator. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA, 2002;288:2015-2022. Doi: 10.1001/jama.288.16.2015
7. Collins AJ, Foley RN, Chavers B, et al. US Renal Data System 2013 Annual Data Report. Am J Kidney Dis 2014;63(suppl):A7, e1-476. Doi: 10.1053/j.akd.2012.11.031.
8. Jardine MJ, Kang A, Zoungas S, et al. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ, 2012. 13:e3533. Doi: 10.1136/bmj.e3533
9. Wyatt CM, Spence JD. Folic acid supplementation and chronic kidney disease progression. Kidney International, 2016. 90, 1144–1145; http://dx.doi.org/10.1016/j.kint.2016.09.019
10. Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China. The CSPPT Randomized Clinical Trial. JAMA, 2015. 313:1325–1335. Doi: 10.1001/jama.2015.2274.
11. Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the renal substudy of the China Stroke Primary Prevention Trial. JAMA Intern Med, 2016. 176:1443–1450. Doi: 10.1001/jamainternmed.2016.4687.
12. Spence JD, Stampfer MJ. Understanding the complexity of homocysteine lowering with B vitamins: the potential role of subgroup analyses. JAMA, 2011. 306:2610–2611. Doi: 10.1001/jama.2011.1834